Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Protective effects of lutein and candesartan co-treatment in diabetic retinopathy using the hyperglycemic Ins Akita/+ mouse model

Long Hin Li; Wei Wang; KC Tam; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1757. doi:

ARVO Annual Meeting Abstract June 2020

Lycium barbarum polysaccharides protected against Amyloid beta 1-40 oligomers-induced adult retinal pigment epithelium 19 cell damage

Ming Yang; Amy CY Lo; Wai Ching Lam

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4917. doi:

ARVO Annual Meeting Abstract July 2019

Application of the anti-inflammatory ocular neuropeptide alpha-melanocyte stimulating hormone (α-MSH) suppresses damage in retinas with ischemia/reperfusion

Andreas A Towers; Nayan Sanjiv; Tat Fong Ng; Amy CY Lo; Andrew W Taylor

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):769. doi:

ARVO Annual Meeting Abstract July 2019

Retinal function, retinal vasculature and physical development were more severely affected in pups from hyperglycemia mice after oxygen-induced retinopathy

Kwan Wun Tsang; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1659. doi:

ARVO Annual Meeting Abstract July 2019

Lycium Barbarum Polysaccharides as a Potential New therapy to Prevent Corneal Scarring

Sum Sum Kwok; Francisca SY Wong; Amy CY Lo; Yau Kei Chan; Tommy Chun-Yan Chan; Kendrick Co Shih

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4659. doi:

ARVO Annual Meeting Abstract July 2019

The Effect of Hyperglycemia on Gut Microbial diversity, Ocular Surface Inflammation and Corneal Re-epithelialization after Alkaline Chemical Injury in Mice

Yashan Bu; Kendrick Co Shih; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5103. doi:

ARVO Annual Meeting Abstract July 2019

Effect of lutein in early diabetic retinopathy using the Ins2Akita mice

Amy CY Lo; Wei Wang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5365. doi:

ARVO Annual Meeting Abstract July 2019

Comparison of the effects of intravitreal aflibercept, bevacizumab and ranibizumab on retinal function and vasculature after oxygen-induced retinopathy

wai ching Lam; Jessica Tsang; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5407. doi:

ARVO Annual Meeting Abstract July 2018

Abnormal retinal function and vasculature in mouse neonates with hyperglycemic mother after oxygen-induced retinopathy

Kwan Wun Tsang; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5466. doi:

ARVO Annual Meeting Abstract July 2018

Study on the effect of lutein in an experimental model of diabetic retinopathy using the Ins2Akita mice

Wei Wang; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):206. doi:

ARVO Annual Meeting Abstract June 2017

Effect of Photobiomodulation on a Retinal Ischemia Rat Model

Hongyi Zheng; Jennifer W.H. SHUM; Amy CY Lo; Jimmy Lai

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2566. doi:

ARVO Annual Meeting Abstract June 2017

Biocompatibility and stability of doxycycline-terminable intraocular drug delivery cell-encapsulating device

Ken K. Tsang; Francisca S.Y. Wong; KM Yao; Barbara P. Chan; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4447. doi:

ARVO Annual Meeting Abstract June 2017

Effect of hypoxia on autophagy in R28 cells under low and high glucose conditions

Larissa Ho Ching Tang; Frederic K.C. Fung; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5190. doi:

ARVO Annual Meeting Abstract September 2016

Blockade of Angiotensin II retards the progression of diabetic retinopathy through downregulating Muller cell-derived VEGF

PENG QIN; Amy CY Lo; Ian Wong

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2119. doi:

ARVO Annual Meeting Abstract September 2016

Loss of retinal microglia exacerbates vascular outcomes in mouse oxygen-induced retinopathy model

Jin Liu; Sookja Chung; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2235. doi:

ARVO Annual Meeting Abstract September 2016

NAMPT inhibitors are Selectively Toxic to Human Pluripotent Stem Cells (hPSC) and can Minimize Tumorigenic Potential of hPSC-derived RPE cells

Qinghui Hu; Amy CY Lo; David Wong; Kenneth Richard Boheler

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6544. doi:

ARVO Annual Meeting Abstract June 2015

Effect of Candesartan on the development of diabetic retinopathy in a diabetes mouse model

PENG QIN; Amy CY Lo; Ian Wong

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):191. doi:

ARVO Annual Meeting Abstract June 2015

Terminable cell-based GDNF delivery device for intravitreal applications

Amy CY Lo; Francisca S. Y. Wong; Kwok Ming Yau; Barbara P Chan

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):257. doi:

ARVO Annual Meeting Abstract June 2015

Spatial and temporal analysis of retinal microglia in mouse oxygen-induced retinopathy model

Jin Liu; Sookja Kim Chung; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):424. doi:

ARVO Annual Meeting Abstract April 2014

In vivo evaluation of hyaluronic acid based in situ hydrogel for prolonged release of Avastin by intravitreal injection

Ying Chau; Yu Yu; Laurence Lau; Amy CY Lo

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5261. doi:

1 2

Next 20 Results »

Advertisement